2,389
Views
14
CrossRef citations to date
0
Altmetric
Short Communication

Exploring and Validating Physicochemical Properties of Mangiferin Through GastroPlus® Software

, , , , , & show all
Article: FSO167 | Received 05 Aug 2016, Accepted 01 Nov 2016, Published online: 16 Jan 2017

References

  • Kelly F. Use of antioxidants in the prevention and treatment of disease. J. Int. Fed. Clin. Chem. 10(1), 21–23 (1998).
  • Matkowski A, Kus P, Goralska E, Wozniak D. Mangiferin – a bioactive xanthonoid, not only from mango and not just antioxidant. Mini Rev. Med. Chem. 13(3), 439–455 (2013).
  • Ojewole JA. Antiinflammatory, analgesic and hypoglycemic effects of Mangifera indica Linn. (Anacardiaceae) stem-bark aqueous extract. Methods Find Exp. Clin. Pharmacol. 27(8), 547–554 (2005).
  • Muruganandan S, Srinivasan K, Gupta S, Gupta PK, Lal J. Effect of mangiferin on hyperglycemia and atherogenicity in streptozotocin diabetic rats. J. Ethnopharmacol. 97(3), 497–501 (2005).
  • Wang RR, Gao YD, Ma CH et al. Mangiferin, an anti-HIV-1 agent targeting protease and effective against resistant strains. Molecules 16(5), 4264–4277 (2011).
  • Leiro J, Arranz JA, Yanez M, Ubeira FM, Sanmartin ML, Orallo F. Expression profiles of genes involved in the mouse nuclear factor-kappa B signal transduction pathway are modulated by mangiferin. Int. Immunopharmacol. 4(6), 763–778 (2004).
  • Khurana RK, Kaur R, Lohan S, Singh KK, Singh B. Mangiferin: a promising anticancer bioactive. Pharm. Pat. Anal. 5(3), 169–181 (2016).
  • Zhang B, Fang J, Chen Y. Antioxidant effect of mangiferin and its potential to be a cancer chemoprevention agent. Lett. Drug Des. Discov. 10, 239–244 (2013).
  • Kavitha M, Nataraj J, Essa MM, Memon MA, Manivasagam T. Mangiferin attenuates MPTP induced dopaminergic neurodegeneration and improves motor impairment, redox balance and Bcl-2/Bax expression in experimental Parkinson's disease mice. Chem. Biol. Interact. 206(2), 239–247 (2013).
  • Beltran AE, Alvarez Y, Xavier FE et al. Vascular effects of the Mangifera indica L. extract (Vimang). Eur. J. Pharmacol. 499(3), 297–305 (2004).
  • Ma H, Chen H, Sun L, Tong L, Zhang T. Improving permeability and oral absorption of mangiferin by phospholipid complexation. Fitoterapia 93, 54–61 (2014).
  • Tian X, Gao Y, Xu Z et al. Pharmacokinetics of mangiferin and its metabolite-norathyriol, Part 1: systemic evaluation of hepatic first-pass effect in vitro and in vivo. Biofactors 42(5), 533–544 (2016).
  • Tian X, Xu Z, Li Z et al. Pharmacokinetics of mangiferin and its metabolite-norathyriol, Part 2: influence of UGT, CYP450, P-gp, and enterobacteria and the potential interaction in Rhizoma Anemarrhenae decoction with timosaponin B2 as the major contributor. Biofactors 42(5), 545–555 (2016).
  • Louisa M, Soediro TM, Suyatna FD. In vitro modulation of P-glycoprotein, MRP-1 and BCRP expression by mangiferin in doxorubicin-treated MCF-7 cells. Asian Pac. J. Cancer Prev. 15(4), 1639–1642 (2014).
  • Wang X, Gu Y, Ren T et al. Increased absorption of mangiferin in the gastrointestinal tract and its mechanism of action by absorption enhancers in rats. Drug Dev. Ind. Pharm. 39(9), 1408–1413 (2013).
  • Liu H, Wu B, Pan G et al. Metabolism and pharmacokinetics of mangiferin in conventional rats, pseudo-germ-free rats, and streptozotocin-induced diabetic rats. Drug Metab. Dispos. 40(11), 2109–2118 (2012).
  • Bock C, Waldmann KH, Ternes W. Mangiferin and hesperidin metabolites are absorbed from the gastrointestinal tract of pigs after oral ingestion of a Cyclopia genistoides (honeybush tea) extract. Nutr. Res. 28(12), 879–891 (2008).
  • Yang X, Zhao Y, Chen Y et al. Host–guest inclusion system of mangiferin with beta-cyclodextrin and its derivatives. Mater. Sci. Eng. C: Mater. Biol. Appl. 33(4), 2386–2391 (2013).
  • Bhattacharyya S, Ahmmed SM, Saha BP, Mukherjee PK. Soya phospholipid complex of mangiferin enhances its hepatoprotectivity by improving its bioavailability and pharmacokinetics. J. Sci. Food Agric. 94(7), 1380–1388 (2014).
  • Zheng Y, Wang YJ. Physicochemical property and percutaneous permeability in vitro of mangiferin liposomes. World Phytomedicines 1(2), 147–150 (2014).
  • de Souza JRR, Feitosa JPA, Ricardo NMPS et al. Spray-drying encapsulation of mangiferin using natural polymers. Food Hydrocoll. 33(1), 10–18 (2013).
  • Moura U, Barbosa M, Genro C, Seibel D, Gomes P, Raffin P. Development and characterization of mangiferin nanocapsules. J. Pharm. Pharmacogn. Res. 2(1), S34 (2014).
  • Fasinu P, Pillay V, Ndesendo VM, du Toit LC, Choonara YE. Diverse approaches for the enhancement of oral drug bioavailability. Biopharm. Drug Dispos. 32(4), 185–209 (2011).
  • Khurana RK, Rao S, Beg S, Katare OP, Singh B. Systematic development and validation of a thin-layer densitometric bioanalytical method for estimation of mangiferin employing analytical quality by design (AQbD) approach. J. Chromatogr. Sci. 54(5), 829–841 (2016).
  • Jantratid E, Janssen N, Reppas C, Dressman JB. Dissolution media simulating conditions in the proximal human gastrointestinal tract: an update. Pharm Res. 25(7), 1663–1676 (2008).
  • Bharate SS, Kumar V, Vishwakarma RA. Determining partition coefficient (log P), distribution coefficient (log D) and ionization constant (pKa) in early drug discovery. Comb. Chem. High Throughput Screen. 19(6), 461–469 (2016).
  • Sun H, Zhao H. Physiological drug distribution and protein binding. In: Applied Biopharmaceutics and Pharmacokinetics (7th Edition). Shargel L, Pong SW, Yu ABC ( Eds). McGraw-Hill Medical, New York, USA, Chapter 10 (2012).
  • Paschke A, Neitzel P, Walther W, Schu G. Octanol/water partition coefficient of selected herbicides: determination using shake-flask method and reversed-phase high-performance liquid chromatography. J. Chem. Eng. Data 49, 1639–1642 (2004).
  • Bandyopadhyay S, Katare OP, Singh B. Optimized self nano-emulsifying systems of ezetimibe with enhanced bioavailability potential using long chain and medium chain triglycerides. Colloids Surf. B. Biointerfaces 100, 50–61 (2012).
  • Khurana RK, Beg S, Lal D, Katare OP, Singh B. Analytical quality by design approach for development of a validated bioanalytical UPLC method of docetaxel trihydrate. Curr. Pharm. Anal. 11(3), 180–192 (2016).
  • Beg S, Sharma G, Thanki K, Jain S, Katare OP, Singh B. Positively charged self-nanoemulsifying oily formulations of olmesartan medoxomil: systematic development, in vitro, ex vivo and in vivo evaluation. Int. J. Pharm. 493(1–2), 466–482 (2015).
  • Fagerholm U, Johansson M, Lennernas H. Comparison between permeability coefficients in rat and human jejunum. Pharm. Res. 13(9), 1336–1342 (1996).
  • Chemicon International, a division of Serologicals® Corporation. Multidrug resistance direct dye efflux assay. Cat. No. ECM910 (2016). http://search.cosmobio.co.jpcosmo_search_p/search_gate2/docs/CMN_/ECM910.20050610.pdf.
  • Daniel WW. Biostatistics: a Foundation for Analysis in the Health Sciences (5th Edition). Wiley & Sons, New York, USA (1991).
  • Vaghani S, Vasanti S, Chaturvedi K, Satish CS, Jivani NP. Stomach-specific drug delivery of 5-fluorouracil using ethylcellulose floating microspheres. Pharm. Dev. Technol. 15(2), 154–161 (2010).
  • Nandgude TD, Bhise KS, Gupta VB. Characterization of hydrochloride and tannate salts of diphenhydramine. Indian J. Pharm. Sci. 70(4), 482–486 (2008).
  • US FDA ICH Guideline. Validation of analytical procedures: text and methodology. Q2 (R1) (2005). www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm265700.htm.
  • Huang HL, Lee WM. Enhanced naphthalene solubility in the presence of sodium dodecyl sulfate: effect of critical micelle concentration. Chemosphere 44(5), 963–972 (2001).
  • Acosta J, Sevilla I, Salomón S, Nuevas L, Romero A, Amaro D. Determination of mangiferin solubility in solvents used in the biopharmaceutical industry. J. Pharm. Pharmacogn. Res. 4(2), 49–53 (2016).
  • Singh SK, Kumar Y, Kumar SS, Sharma VK, Dua K, Samad A. Antimicrobial evaluation of mangiferin analogues. Indian J. Pharm. Sci. 71(3), 328–331 (2009).
  • FooDB. Showing compound mangiferin (FDB012803). http://foodb.ca/compounds/FDB012803.
  • Abdallah HM, Al-Abd AM, El-Dine RS, El-Halawany AM. P-glycoprotein inhibitors of natural origin as potential tumor chemo-sensitizers: a review. J. Adv. Res. 6(1), 45–62 (2015).
  • Xuejian L, Cai DZ, Gang D et al. Mangiferin penta-esterified derivative. CN102432601 A (2014). =https://www.google.com/patents/CN102432601A?cl=en.
  • Qin LJ. Lipase-catalyzed synthesis of mangiferin sugar ester in non-aqueous organic medium and its anti-inflammatory activity (2011). www.dissertationtopic.net/doc/1501951.
  • Kulkarni VM, Rathod VK. A novel method to augment extraction of mangiferin by application of microwave on three phase partitioning. Biotechnol. Rep. 6, 8–12 (2015).
  • Chauhan RS, Dutt P. Swertia ciliata – a new source of mangiferin, amaroswerin and amarogentin. J. Biol. Active Prod. Nat. 3(2), 161–165 (2013).
  • Jyotshna, Khare P, Shanker K. Mangiferin: a review of sources and interventions for biological activities. Biofactors 42(5), 504–514 (2016).
  • Negi LM, Tariq M, Talegaonkar S. Nano scale self-emulsifying oil based carrier system for improved oral bioavailability of camptothecin derivative by P-glycoprotein modulation. Colloids Surf. B, Biointerfaces 111, 346–353 (2013).
  • Liang XJ, Chen C, Zhao Y, Wang PC. Circumventing tumor resistance to chemotherapy by nanotechnology. Methods Mol. Biol. 596, 467–488 (2010).